P-Glycoprotein-Evading Anti-tumor Activity of a Novel Tubulin and HSP90 Dual Inhibitor in a Non-small-cell Lung Cancer Model

Qiu Zhang(Shandong University), Bing Yan(Shandong University)

Journal of Pharmacological Sciences

January 1, 2014

10.1254/jphs.14050fp

Cited by 14

Related Papers

Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo

|Cell Death and Disease|2014|17

The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo

|PLoS ONE|2015|15

Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting β-catenin in mice

|PLoS ONE|2020|11